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Phagocytosis by adherent human monocytes ofhuman erythroeytes (RBC), sulfatide-enriched by incubation with 10 -t: to I0 ~ M cerebroside sulfate, 
was enhanced approx. 6-fold. Increased phagocytosis was observed only in RBC opsonized with fresh plasma, and not in non-opsonized or
seram-opsonized RBC. Increased phago~ytosis was immunoglobulin- and complement independent. Thrombospondia and yon Willebraod factor, 
present in plasma but not in ~ru;aa, and bindin5 selectively to sulfatides, are likely mediators of the enhanced plmgoeytosis. 
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1. INTRODUCTION 
Suifatides (sulfated glycolipids) are constitutive ele- 
monts of RBC membrane complex glyeolipids, together 
with gangliosides and fucoglycolipids [1 ]. According to 
their percent distribution (approx. 0.16% of total com- 
plex lipids) [1,2] they rank in the lowest range, if com- 
pared to PS (13%), PE (27-31%) or sphingolipids (24- 
27% of total complex lipids) [2]. Sulfatides are confined 
to the external leaflet of the RBC bilayer [1,2], play a 
role in cell adhesion in different cell types [4], and bind 
specifically and with high affinity to laminin [5], throm- 
bospondin [6] and yon Willebrand factor [7]. We report 
here that addition of  minute amounts of sulfatides to the 
RBC membrane remarkably increases RBC phagocyte. 
sis by adherent human monocytes. Previous opsoniza- 
tion of sulfatide-enriched RBC in plasma, but not in 
serum, is necessary and binding of leg  or complement 
does not occur. Binding of thrornbospondin or yon Wil- 
lebrand factor to the sulfatide-enriched RBC represents 
a likely trigger for phagoeytosis. 
2. EXPERIMENTAL 
2.1. Materials 
Sulfatide (¢erebroside sulfate from bovine brain), PC, PS, alkaline 
Correspondence address: P. Arese, Dipartimento di Genetic.a, Blain- 
8is, Chimiea medica, Via Santena 5his 10126 Torino, Italy. Fax: (39) 
(11) 67 4O 40. 
Abbreviations: BSA, bovine serum albumin, type V; HEPES, 4-(2- 
hydroxyethyl)-l.piperazineethane.~ulfonic acid; leG, immanaglnbulin 
G; PBS, phosphate-buffered ~line; PBS-alucose, PBS supplement,~d 
with 10 mM glucose; PC, pho~phatidylcholine; PE, phosphatidyletha- 
nolamine; PS, phosphatidylserine; RBC, erythrocyte(s), 
phosphatase-conjugated rabbit anti-human IBG, ¢~11 culture products, 
buffers and other standard chemicals were from Sig~m (St. Louis, 
MO). Tritiated cerebroside sulfate was prepared according to [B] truing 
[~H]borhydridc from Amersham International {Backs, UK). 
2.2. Enrichment ofRBC with sulfatides 
RBC {group 0, Rh positive) were isolated from venous blood freshly 
drawn from healthy volunteers of both sexes. Informed consent was 
obtained from each donor. Blood was anticoagulat~d with 6 IU/ml 
heparin. After removal of plasma nd huffy coat by aspiration and 3 
washes in HEPES-saline buffer (Noel 140 raM, HEPES 5 raM, glu- 
cose 5.5 raM, pH 7.4), RBC were enriched with sulfatides. Cerebroside 
sulfate was presented as a dispersion obtained by soni~ting sulfatide 
suspensions (10 -s to 10 -~" M in RPMI 1640, pH 7.4) for ~ x 20 s with 
60 s cooling intervals between each sonication cycle. Immediately alter 
sonication, RBC were added to RPMI 1640 m~lium containing the 
dispersed ~ulfatide at 1% hematocrit for 60 rain at 37"C. 
2.3. Quantttatio, f RBC-as~oeiated added attlfattde 
RBC-associated salfatide was qtmntitated after treatment with 
[~H]sulfatide (8 × l0 s cpm//,tg sulfatide), presented to the RBC as 
sulfatide dispersion in RPMI 1640 medium. After 60 rain incubation 
at 370C, RBC were wasn~ 4 times in HEPES-saline buffer and 
hypotonic hemoglobin-fre~ 8hosts were prepared [9]. After protein 
determination by the bicinchonini¢ acid method (Pierce) and liquid 
scintillation counting, gBC-a~ociate~d salfatide was expressed as epm 
per/,18 host protein. 
2.4. Opsoni'.atian ofRBC 
To a volume of packed, washed RBC was added an equal volume 
of frash autologous ~ram, complement-inactivated (30 rain at 56"C) 
~erum or plasma, and the cell suspension was incubated for 30 rain at 
37"C, 
2.5. Preparation of adlterent human monocytes 
Mononaclcar cells were separated from fresh human blood col- 
lected in heparin (6 1U/ml blood) [10]. Separated lympho-monocytes 
were washed 3 times in PBS, resuspended in RPMI 1640 medium 
supplemented with 10% (v/v) aatologous serum and plated at 1-2.10 ~ 
cells/well in 24-well plates. After i h incubation i  a humidified inca- 
bator (5% COy95% air, 37"C), non-adherent ceils were removed by 
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Fig. 1. Relationship between sulfatide concentration in the incubation 
medium and sulfatide associated to the RBC membrane. Typical ex- 
periment out of four with similar results. 
washing the wells with lukewarm RPM[ 1640 medium. Adherent mon- 
o~3'tes were reincubated with the same medium for 5-10 h until start- 
ing the phagocytosis experiments. 
2.6. Quantitatlon ofphagocytosis 
Fifteen #1 opsonized RBC (hematocrit 10%) were added to each well 
containing approx. 50,000 monocytes. The ratio RBC/monocyte was 
approx. 300. After 1 h incubation at 370C in a humidified incubator 
(see above) non-ingested/non-adherent RBC were removed by aspira. 
tion and 3 washes with PBS. Non-ia~ested, adherent RBC were os- 
motically lysed by addition of ice-enid istilled water for 20 s, followed 
by an additional wash with PBS to remove debris and free hemoglo- 
bin. After solubilization of monocytes containin 8 ingested RBC by 
adding to each well 1 ml solubilizing solution (0.1 N NaOH, 0.025% 
(v/v) Triton X-100), phagocytosis was quantified by measuring in- 
gested hemoglobin by luminol-elicited luminescence in the presence of 
tert-butylhydroperoxide as an electron donor [11]. 
2.7. Quantitatton fbound [gG 
After opsonization with serum or plasma, RBC were washed 5times 
with RPMI 1640 medium at 4'C and suspended at 10% hematoerit 
in PBS-G supplemented with 2% (w/v) BSA and alkaline phosphatase- 
conjugated rabbit anti-human lgG, diluted 1:1,000 (v/v). After 2 h 
incubation at room temperature, RBC were washed 5 times with 
PBS-G supplemented with 2% BSA (w/v) and hypotonic ghosts pre- 
pared [9l. After 8host solubilization i 0.5% (v/v) Triton X-100, rabbit 
alkaline phosphatase-eonjugated nti-human IgGs were quantitated 
speotrophotometrically t 405 nm [12]. 
3. RESULTS 
The relationship between sulfatide concentration in 
the incubation medium and exogenous ulfatide associ- 
ated to the RBC membrane is shown in Fig. 1. Incuba- 
tion of  RBC in a medium containing 10-'-" to 10 -'j M 
sulfatide (presented as sonieated sulfatide suspension) 
causes a modest increase in sulfatide association to the 
RBC membrane. A thousand-fold increase in sulfatide 
concentration i the incubation medium from 10 -~2 to 
10 -9 M sulfatide brought about a 2-fold increase in 
sulfatide associated to RBC membrane. Above 10 -'~ M 
sulfatide concentration i  the incubation medium, the 
curve becomes much steeper, indicating a linear rela- 
tionship between sulfatide concentration i the incuba- 
tion medium and sulfatide associated to the RBC mem- 
brane. 
Enrichment of RBC membrane with sulfatide in- 
creases RBC phagocytosis by adherent monocytes 
(Figs. 2 and 3). The increase is small (1.7-fold), non- 
significant and not related to the amount of RBC-asso- 
eiated sulfatide~ when sulfatide-enriched RBC were not 
opsonized (Fig. 3). When sulfatide-enriched RBC were 
opsonized with autologous plasma, enhancement of 
phagocytosis was very marked. Maximum increase was 
approx. 6-fold over non-enriched controls when enrich- 
merit was performed by pre-incubating RBC at 10 -9 M 
sulfatide (Fig. 2). Increase in phagocytosis was not 
modified when RBC were opsonized with complement. 
inactivated plasma, but dropped to control values when 
opsonization was carried out with serum instead of 
plasma (Figs. 2 and 3). 
Dependence between enhancement of phagoeytosis 
and the amount of RBC-associated sulfatide was also 
studied. As shown in Fig. 2, there is a narrow range of 
sulfatide nrichment which is associated with 5- to 6.5- 
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Fig. 2. Relationship between sullhtide con~ntration i  incubation 
medium and RBC phagocytosis by adherent human monocytes, i  
RBC opsonized in plasma; z~, RBC opsonized in ~rum. Phagocytic 
index, ratio between umber of phagocytosed sulfatide-enriched RBC 
vs, control RBC/monocyte. Each experimental value is the average of 
four distinct phagocytosis wells. Typical experiment oat of three with 
similar esults. 
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Fig, 3. Dependence of phagocytosis of sulfatide-enriched RBC from 
opsonization. Sulfatide-enriched RBC were opsonized in RPMI 1640 
medium (RPMI), in fresh autologous plasma (P). in complement- 
inactivated plasma (P56) and in fresh aatologous erum (S). 
Phagocytic index, ratio between umber of phagoeytosed sulfatide- 
enriched RBC vs. control RBC/monoeyte. Mean values ± S.D. of four 
experiments. Each experiment is the average of four distinct phagoey. 
tosis wells. 
fold enhancement of phagocytosis. This range is ob- 
tained by incubating RBC in a 10 -~2 to 10 -9 M sulfatide 
suspension. Further increase in sulfatide was accompa- 
nied by a sharp decrease in phagocytosis. Phagocytosis 
was back to control values when RBC were sulfatide. 
enriched by incubating RBC in sulfatide suspensions at
10 -s sulfatide. Interestingly, the diminution i  phagocy- 
tosis corresponds with the steep portion of the biphasic 
curve in Fig. 1, and with the association of large num- 
bers of sulfatide molecules to the RBC. 
Binding of IgG was monitored by phosphatase-con- 
jugated anti-human IgG (not shown). Repeated assays 
performed on RBC enriched with different amounts of 
sulfatide and opsonized by incubation in autoiogous 
plasma or serum for 1 h at 370C constantly gave nega- 
tive results, indicating that RBC-associated sulfatides 
did not cause increased eposition of IgG. 
4. DISCUSSION 
We show here that addition of small amounts of sul- 
fatides to the membrane of human RBC remarkably 
increased their phagoeytosis by adherent human mon- 
ocytes. The highest increase in phagocytosis was ob- 
served after incubation of RBC in sulfatide dispersions 
at 10 -l~- to 10 -9 M sulfatide. We observed proportional- 
ity between added sulfatide and increascd phagocytosis 
only in a narrow range of salfatide supplementation. 
incubation of RBC at higher salfatide concentratiolls 
led to a decrease in phagoeytosis. This behavior was 
observed at sulfatide concentrations corresponding to
or surpassing the micellar point concentration (B. Ces- 
taro, personal communication). 
The increase in phagoeytosis was not mediated by 
increased eposition of autologous IgG and was not 
complement-dependent. Therefore, autoantibodies di- 
rected against sulfatides or autoantibodies bound un- 
specifically to RBC regions with increased ensities of 
negative charges can be excluded from playing a role. 
Also, we can exclude that exogenously associated sulfur- 
ides may activate the alternative complement pathway 
and mediate a complement-dependent phagocytosis. 
Opsonization with fresh, platelet-containing plasma 
was necessary in order to obtain phagocytosis stimula- 
tion. Opsonization with fresh autologous serum was 
ineffective. Thus, some plasma component which is no 
longer present in serum could mediate increased 
phagocytosis. Considering proteins known to bind to 
sulfated glycolipids with high affinity, laminin is only 
present in basal membranes [13], whereas throm- 
bospondin and yon Willebrand factor are both present 
in plasma [14,15]. Thrombospondin s produced by 
platelets, monocytes, endothelial cells and a number of 
other cell lines and is present in plasma at concentra- 
tions varying between 97 and 163 ng/ml [14]. Von Wil- 
lebrand factor is not produced by platelets, and is pres- 
ent in plasma t the concentration f approx. 20 ng/ml 
[15]. Both factors are depleted in sermn following plate- 
let aggregation and binding of thrombospondin to fi- 
brinogen [14, ! 5]. Both factors bind to sulfated glycolip- 
ids with high affinity, but thrombospondin has 3 times 
higher affinity than yon Willebrand factor [4]. For these 
considerations, thrombospondin seems to be a likely 
candidate as a mediator for increased phagocytosis. 
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